Sam Adams

Sam Adams is an experienced finance and business operations leader with a diverse background in the healthcare and education sectors. Currently serving as the Director of Finance and Business Operations at Endsulin, Inc., a gene therapy company focused on Type 1 diabetes treatment, Adams previously co-founded Fenster Analytics and held key roles at Cardiac Science, Wisconsin Center for Education Products and Services, Stealth Therapeutics, Echometrix, and GE Healthcare. Educational credentials include an MBA in Entrepreneurship and Marketing from the University of Wisconsin-Madison and a BA in International Political Economy from Colorado College.